Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Biomedical Nanotechnology
|
June 21, 2016
First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development
Oliver Jonas, David Calligaris, Kashi Reddy Methuku, et al.
Cell Systems
|
March 19, 2018
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes
Spencer S Watson, Mark Dane, Koei Chin, et al.
Annals of Surgery
|
May 4, 2026
Implantable Microdevices for In Vivo Assessment of Chemotherapy Response in Patient Derived Organoid Orthotopic Pancreatic Cancer Models
Oliver J Standring, Julien T Hohenleitner, Lyudmyla Demyan, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
April 11, 2025
Feasibility of MRI-Guided Transperineal Implantation of Microdevices for Drug Delivery and Response Assessment in Prostate Cancer
Quinn Rainer, Kemal Tuncali, Wooseok Ahn, et al.
Radiology. Imaging Cancer
|
August 29, 2025
An Interventional Radiology Method for In Situ Assessments of Cancer Drug Response: Preclinical Development, Feasibility, and Safety
Sharath K Bhagavatula, Ryan Reichert, Sebastian W Ahn, et al.
Cancer Research
|
November 22, 2022
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Jesse C Patterson, Andreas Varkaris, Peter J P Croucher, et al.
Elife
|
June 1, 2017
Synergistic interactions with PI3K inhibition that induce apoptosis
Yaara Zwang, Oliver Jonas, Casandra Chen, et al.
Cancer Discovery
|
January 27, 2016
Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression
Madeleine J Oudin, Oliver Jonas, Tatsiana Kosciuk, et al.
Science Translational Medicine
|
September 6, 2023
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas
Pierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, et al.
Nature Medicine
|
December 27, 2016
Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
Shawn M Davidson, Oliver Jonas, Mark A Keibler, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Biomedical Nanotechnology
|
June 21, 2016
First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development
Oliver Jonas, David Calligaris, Kashi Reddy Methuku, et al.
Cell Systems
|
March 19, 2018
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes
Spencer S Watson, Mark Dane, Koei Chin, et al.
Annals of Surgery
|
May 4, 2026
Implantable Microdevices for In Vivo Assessment of Chemotherapy Response in Patient Derived Organoid Orthotopic Pancreatic Cancer Models
Oliver J Standring, Julien T Hohenleitner, Lyudmyla Demyan, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
April 11, 2025
Feasibility of MRI-Guided Transperineal Implantation of Microdevices for Drug Delivery and Response Assessment in Prostate Cancer
Quinn Rainer, Kemal Tuncali, Wooseok Ahn, et al.
Radiology. Imaging Cancer
|
August 29, 2025
An Interventional Radiology Method for In Situ Assessments of Cancer Drug Response: Preclinical Development, Feasibility, and Safety
Sharath K Bhagavatula, Ryan Reichert, Sebastian W Ahn, et al.
Cancer Research
|
November 22, 2022
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Jesse C Patterson, Andreas Varkaris, Peter J P Croucher, et al.
Elife
|
June 1, 2017
Synergistic interactions with PI3K inhibition that induce apoptosis
Yaara Zwang, Oliver Jonas, Casandra Chen, et al.
Cancer Discovery
|
January 27, 2016
Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression
Madeleine J Oudin, Oliver Jonas, Tatsiana Kosciuk, et al.
Science Translational Medicine
|
September 6, 2023
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas
Pierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, et al.
Nature Medicine
|
December 27, 2016
Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
Shawn M Davidson, Oliver Jonas, Mark A Keibler, et al.
Page
of 5